BeOne Medicines
Pauline MICHEL ROCHEREAU currently serves as the Regional Clinical Study Associate Manager at BeiGene, having joined the company in August 2022. Previous roles include Acting Associate Regional Clinical Study Manager and Senior Associate in Clinical Operations at the same organization. Prior experience includes working as a Clinical Research Associate 2 / Site Manager and Clinical Research Associate 1 / Site Manager at IQVIA from August 2019 to August 2022. Earlier positions include Clinical Trial Assistant and Clinical Research Associate Trainee at the Institut de Chirurgie guidée par l'Image (IHU Strasbourg) and a background in social pedagogy and psycho-sociology. Education includes a Clinical Trials degree from Université de Médecine de Strasbourg and a Master’s degree in Sociology and Psychology from the University of Strasbourg.
This person is not in any offices
BeOne Medicines
36 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.